Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Stevia rebaudiana contains steviol glycosides that are 200-300 times sweeter than sucrose and activate AMPK/PI3K/Akt pathways for glucose regulation. These compounds also scavenge free radicals and inhibit inflammatory NF-κB, STAT1, and IRF3 pathways while modulating antioxidant enzymes SOD, CAT, and GPx.
Reported Benefits (Provisional)
Origin & History
Stevia rebaudiana, commonly known as Sweetleaf or Stevia, is a perennial shrub indigenous to subtropical high-altitude regions of Paraguay and Brazil. It is globally recognized for its intensely sweet, calorie-free compounds, making it a significant botanical for metabolic and cardiovascular health.
Research Narrative (Provisional)
Extensive research, including human clinical trials, supports Stevia's role in blood sugar management and as a safe, non-caloric sweetener. Studies also indicate potential cardiovascular benefits and antioxidant activity, warranting further investigation into its broader therapeutic applications.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Bioactives: Steviol glycosides (stevioside, rebaudioside A), Polyphenols, Flavonoids - Minerals: Potassium, Calcium, Magnesium, Iron - Vitamins: Small amounts of C and B vitamins - Other: Dietary fiber
Reported Mechanism (Provisional)
Steviol glycosides (stevioside, rebaudiosides A-F) activate AMPK/PI3K/Akt pathways for glucose metabolism and inhibit α-glucosidase enzyme activity. Phenolic compounds including quercetin and protocatechuic acid scavenge ABTS•+ and superoxide radicals while chelating metal ions (Fe²⁺ IC₅₀ = 2.08 µg/mL). Anti-inflammatory effects occur through inhibition of NF-κB, STAT1, and IRF3 pathways, reducing IL-6, MCP-1, and NO/iNOS production in activated macrophages.
Clinical Narrative (Provisional)
Limited human clinical trials are available, with most evidence from in vitro and animal studies. Preclinical research shows beverages with 1.25-2.5% stevia demonstrate 3-5x higher TEAC and 5-7x higher ORAC antioxidant capacity compared to controls (p<0.05). Animal studies indicate stevioside activates AMPK for glucose regulation and increases antioxidant enzyme activity. Extensive research supports stevia's safety as a non-caloric sweetener, but large-scale human RCTs with specific clinical endpoints like HbA1c reductions require further investigation.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.